Loading the Newsroom

A pancreatic cancer survival breakthrough hits 13.2 months, but the IRA threatens the incentives that made it possible.

David Ellison’s Skydance-led deal is delayed until antitrust rulings, leaving employees split between layoffs and survival bets.